94 related articles for article (PubMed ID: 9212453)
1. Synthesis and pharmacological activities of some 2,3,4,5-tetrahydro[1,5]benzo[f]thiazepines.
Saturnino C; Saturnino P; De Martino G; Lancelot JC; Perrine D; Rault S; Robba M; Rossi F
Farmaco; 1997 Mar; 52(3):183-6. PubMed ID: 9212453
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin antagonistic action of new 1,5-benzothiazepines derived from diltiazem.
Suzuki T; Ohashi M; Takaiti O; Harigaya S
Arzneimittelforschung; 1994 Jan; 44(1):3-6. PubMed ID: 8135875
[TBL] [Abstract][Full Text] [Related]
3. Optically active 1,5-benzothiazepines.
Lévai A
Pharmazie; 1999 Oct; 54(10):719-26. PubMed ID: 10563370
[No Abstract] [Full Text] [Related]
4. Design, synthesis, and biological testing of thiosalicylamides as a novel class of calcium channel blockers.
Mehanna AS; Kim JY
Bioorg Med Chem; 2005 Jul; 13(13):4323-31. PubMed ID: 15927838
[TBL] [Abstract][Full Text] [Related]
5. [New intracellular calcium antagonists. I. Synthesis and pharmacological evaluation of 2,3,4,5-tetrahydro-1,5-benzothiazepine analogs].
Ueyama N; Wakabayashi S; Tomiyama T
Yakugaku Zasshi; 1996 Feb; 116(2):106-24. PubMed ID: 8717278
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of halogen-substituted 1,5-benzothiazepine derivatives and their vasodilating and hypotensive activities.
Inoue H; Konda M; Hashiyama T; Otsuka H; Takahashi K; Gaino M; Date T; Aoe K; Takeda M; Murata S
J Med Chem; 1991 Feb; 34(2):675-87. PubMed ID: 1995892
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.
Atwal KS; Bergey JL; Hedberg A; Moreland S
J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903
[TBL] [Abstract][Full Text] [Related]
8. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
[TBL] [Abstract][Full Text] [Related]
9. Dibenzothiazepinones as potential calcium channel antagonists. I.
Li R; Farmer PS; Quillam MA; Howlett SE
Drug Des Discov; 1993; 10(4):331-42. PubMed ID: 8148472
[TBL] [Abstract][Full Text] [Related]
10. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. XI. Synthesis and biological activity of several naphtho- and quinolino-1,4-thiazine and -1,4-thiazepine derivatives containing the imidazole ring.
Grandolini G; Ambrogi V; Perioli L; D'Eramo D; Bernardini C; Giampietri A
Farmaco; 1997; 52(6-7):379-84. PubMed ID: 9372589
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the chemistry of thieno-annealed O,N- and S,N-containing heterocyclics. 9. Synthesis and calcium channel blocking action of theino-analogs of KT-362].
Erker T
Arch Pharm (Weinheim); 1995 Apr; 328(4):313-6. PubMed ID: 7611826
[No Abstract] [Full Text] [Related]
12. Inhibition of L-type Ca2+ channel by mitochondrial Na+-Ca2+ exchange inhibitor CGP-37157 in rat atrial myocytes.
Thu le T; Ahn JR; Woo SH
Eur J Pharmacol; 2006 Dec; 552(1-3):15-9. PubMed ID: 17054940
[TBL] [Abstract][Full Text] [Related]
13. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. VI. Synthesis and preliminary pharmacological evaluation of 1-alkylaminomethyl-4,5-dihydro-s-triazolo[3,4-d]-1,5-benzothiazepines.
Ambrogi V; Grandolini G; Perioli L; Giampietri A
Farmaco; 1993 May; 48(5):653-64. PubMed ID: 8343212
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors.
Ellis CD; Oppong KA; Laufersweiler MC; O'Neil SV; Soper DL; Wang Y; Wos JA; Fancher AN; Lu W; Suchanek MK; Wang RL; De B; Demuth TP
Bioorg Med Chem Lett; 2006 Sep; 16(18):4728-32. PubMed ID: 16870441
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and biological activities of benzimidazolo[2,1-b] benzo[e]thiazepin-5(10H)-ones.
Rastkari N; Abdollahi M; Ahmadkhaniha R; Shafiee A
Arch Pharm (Weinheim); 2008 Jan; 341(1):49-54. PubMed ID: 18072242
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic aspects of benzothiazepines: a class of antiarrhythmic drugs.
Yadav A; Awasthi A; Rao NK
Eur J Med Chem; 2009 Jan; 44(1):1-6. PubMed ID: 18407379
[TBL] [Abstract][Full Text] [Related]
17. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of JTV519 (K201), a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.
Hachida M; Lu H; Kaneko N; Horikawa Y; Ohkado A; Gu H; Zhang XL; Hoshi H; Nonoyama M; Nakanishi T; Koyanagi H
Transplant Proc; 1999; 31(1-2):996-1000. PubMed ID: 10083444
[No Abstract] [Full Text] [Related]
19. Protective effect of JTV519 on prolonged myocardial preservation.
Hachida M; Lu H; Kaneko N; Nonoyama M; Koyanagi H
Transplant Proc; 1999; 31(1-2):1094. PubMed ID: 10083488
[No Abstract] [Full Text] [Related]
20. Conformationally constrained calcium channel blockers: novel mimics of 1-benzazepin-2-ones.
Barrish JC; Spergel SH; Moreland S; Grover G; Hedberg SA; Pudzianowski AT; Gougoutas JZ; Malley MF
Bioorg Med Chem; 1993 Oct; 1(4):309-25. PubMed ID: 8081861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
